Country: Canada
Language: English
Source: Health Canada
CIMETIDINE
MYLAN PHARMACEUTICALS ULC
A02BA01
CIMETIDINE
600MG
TABLET
CIMETIDINE 600MG
ORAL
100/500
Prescription
HISTAMINE H2-ANTAGONISTS
Active ingredient group (AIG) number: 0111925004; AHFS:
CANCELLED POST MARKET
2017-09-22
1 PRODUCT MONOGRAPH MYLAN-CIMETIDINE (Cimetidine Tablets, USP) 300 MG, 400 MG, 600 MG, 800 MG Histamine H 2 Receptor Antagonist Mylan Pharmaceuticals ULC Date of Preparation: September 2, 2009 85 Advance Road Etobicoke, Ontario Date of Revision: M8Z 2S6 2 PRODUCT MONOGRAPH MYLAN-CIMETIDINE (Cimetidine Tablets, USP) 300 mg, 400 mg, 600 mg, 800 mg PHARMACOLOGICAL CLASSIFICATION Histamine H 2 Receptor Antagonist ACTION AND CLINICAL PHARMACOLOGY Cimetidine, competitively, inhibits the action of histamine on the H 2 receptor of parietal cells, reducing gastric acid output and concentration under basal conditions, and also when stimulated by food, insulin, histamine, pentagastrin, and caffeine. Cimetidine is not an anticholinergic agent. Cimetidine produces a dose-related reduction in nocturnal acid secretion of 47-83 % over a 6 to 8 hour period or of 54% over a 9 hour period following 400 mg b.i.d. or 300 mg q.i.d., respectively, in patients with duodenal ulcer. Mean acid secretion over a 24-hour period is reduced by about 60% or less following oral dosages of 800 mg daily at bedtime, 400 mg b.i.d., or 300 mg q.i.d. Cimetidine indirectly reduces pepsin secretion by decreasing the volume of gastric juice; however, has no substantial effect on lower esophageal sphincter pressure, gastric motility or emptying, or biliary or pancreatic secretion. PHARMACOKINETICS In both healthy individuals and those with peptic ulcer or Zollinger-Ellison syndrome, basal gastric acid secretion is inhibited to a greater extent than is meal-stimulated acid secretion at a given blood concentration of cimetidine. After oral administration, cimetidine is rapidly and well absorbed with a plasma half life of ∼ 2 hrs. An average bioavailability is given between 60-70%, but may be less in elderly 3 patients with reduced renal or hepatic function. The oral bioavailability of a single 800 mg cimetidine tablet is comparable to that of a single dose of two 400 mg cimetidine tablets. Cimetidine is widely distributed and is 15-25% bound to plasma prot Read the complete document